Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00056550
Status:
COMPLETED
Last Update Posted:
2012-10-16
First Post:
2003-03-17
Brief Title:
Assess Incidence of Deep Vein ThrombosisDVTFollowing Administration of Recombinant Human Antithrombin rhAT to Hereditary AntithrombinAT Deficient Patients in High Risk Situations
Sponsor:
rEVO Biologics
Organization:
rEVO Biologics
Organization Data
Organization:
rEVO Biologics
Class:
INDUSTRY
Study ID:
GTC AT III 01002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
rEVO Biologics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None